Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Friedel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Urology|December 24, 1997
Radical retropubic prostatectomy outcomes at a community hospitalF D Gaylis, W E Friedel, O A Armas
Current Molecular Medicine|May 12, 2010
Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancerH Matthes, W E Friedel, P R Bock, et al.
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|September 9, 2004
Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use"P R Bock, W E Friedel, J Hanisch, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Urology|December 24, 1997
Radical retropubic prostatectomy outcomes at a community hospitalF D Gaylis, W E Friedel, O A Armas
Current Molecular Medicine|May 12, 2010
Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancerH Matthes, W E Friedel, P R Bock, et al.
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|September 9, 2004
Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use"P R Bock, W E Friedel, J Hanisch, et al.
Pageof 1